Abstract:The present work involved the synthesis of two novel anti‐cancer drugs derived from a known anticancer drug 4‐nitrobenzaldehyde and a novel drug delivery system based on Carbon quantum dots derived from amino acids, which are hydrophilic and less cytotoxic. The MTT assay results revealed that the CQDs integrated 4‐ nitro benzaldehye (D1) and one of the derivatives (D3) exhibited greater cytotoxic effects on PC3 cells compared to L929 cells and the novel derivative D3 was able to kill the cancer cells as effectively as 4‐nitrobenzaldehyde conjugated with CQDs. The mechanism leading to cell death was identified to be apoptosis in PC3 cancer cell line and the drugs D1 and D3 conjugated with carbon quantum dots were identified as promising candidates for localized drug delivery application in prostate cancer cells. The present work describes the synthesis two novel derivatives of 4‐nitrobenzaldehyde through a single pot microwave assisted green synthetic method and the characterization of the synthesized drugs using UV, IR,1HNMR, Mass spectra and CHN analysis. The structure optimization of the synthesized anticancer agents was carried out using Gaussian 9. Also carbon quantum dots (CQDs) derived from amino acid precursors were synthesized (Cystine and threonine) by microwave assisted method, followed by the integration of CQDS together with 4‐nitrobenzaldehyde and its novel derivatives. The drugs were subjected to targeted drug delivery applications in cancer cell lines (PC3) The MTT assay results revealed that the CQDs conjugated with 4‐nitrobenzaldehye (D1) and one of the derivatives (D3) exhibited greater cytotoxic effects on PC3 cells compared to L929 cells. The outcomes demonstrated that this novel derivative could kill cancer cells as effectively as 4‐nitrobenzaldehyde conjugated with CQDs. Also, the potential cytotoxicity of drugs D1 and D3 were further confirmed by the apoptosis assay using flow cytometry, which also explains that apoptosis is the mechanism underlying cell death in PC3 cancer cells. The autofluorescence test were also carried out in PC3 cells lines and the drugs D1 and D3 showed significant autofluorescence in PE−A (29.9 % and 34.7 %), in Alexa Fluor‐488 (32.6 % and61.1 %) and in Bv510‐A (16.6 % and 23.2 %) respectively. Thus, the synergistic effect of CQDs together with 4‐nitrobenzaldehyde and its derivative drug D3 are indeed a promising medication towards the localized drug delivery applications in prostate cancer cells as well as the autofluorescence results will explore novel arenas in bioimaging applications.

Synthesis of Novel Anticancer Drugs Derived from 4‐nitrobenzaldehyde, and Investigation of Responsive Drug Delivery Systems Based on Carbon Quantum Dots.

N doped-carbon quantum dots with ultra-high quantum yield photoluminescent property conjugated with folic acid for targeted drug delivery and bioimaging applications

Synthesis, characterization, and evaluation of the anticancer properties of pH‐responsive carvacrol‐zinc oxide quantum dots on breast cancer cell line (MDA‐MB‐231)

Combined photodynamic-chemotherapy investigation of cancer cells using carbon quantum dot-based drug carrier system

Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of 4‐Nitrobenzohydrazide Derivatives as Potential Anticancer Agents

Ball-milled graphene quantum dots for enhanced anti-cancer drug delivery

Design, Synthesis, and In Vitro Cytotoxic Studies of Some Novel Arylidene-Hydrazinyl-Thiazoles as Anticancer and Apoptosis-Inducing Agents

Graphene quantum dot formulation for cancer imaging and redox-based drug delivery

Glutamic acid-catalyzed synthesis of dihydroquinazolinone: anticancer activity, electrochemical behavior, molecular docking, dynamics, simulations and drug-likeness studies

Abstract 5756: Silver graphene quantum dots as drug delivery platforms for anti-cancer application

Physico-chemical properties and biological evaluation of graphene quantum dots for anticancer drug susceptibility

Synthesis, biological and electrochemical evaluation of novel nitroaromatics as potential anticancerous drugs

Duplex metal co-doped carbon quantum dots-based drug delivery system with intelligent adjustable size as adjuvant for synergistic cancer therapy

Design, synthesis, and evaluation of novel (E)-N'-(3-allyl-2-hydroxy)benzylidene-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides as antitumor agents

New nanodrug design for cancer therapy: Its synthesis, formulation, in vitro and in silico evaluations

Design, synthesis, and biological evaluation of novel quinoxaline aryl ethers as anticancer agents

A comprehensive review on carbon quantum dots as an effective photosensitizer and drug delivery system for cancer treatment

In the pursuit of novel therapeutic agents: synthesis, anticancer evaluation, and physicochemical insights of novel pyrimidine-based 2-aminobenzothiazole derivatives

Dysprosium-doped carbon quantum dot nanocarrier: in vitro anticancer activity

Novel N-(3-ethynyl Phenyl)-6,7-bis(2-methoxyethoxy)Quinazoline-4-amine Derivatives: Synthesis, Characterization, Anti-cancer Activity, In-silico and DFT Studies

Synthesis of Acid-Activated Reversible Conversion Supramolecular Nanoplatform: Application in Drug Delivery and Anti-Tumor Activity